Meridian Bioscience, Inc. (VIVO)

Jan 31, 2023 - VIVO was delisted (reason: acquired by SD Biosensor and SJL Partners)
33.97
0.00 (0.00%)
Last trade price

Balance Sheet (Annual)

Millions USD. Fiscal year is Oct - Sep.
Year 2022202120202019201820172016201520142013 2012 - 1996
Cash & Equivalents
81.4549.7753.5162.460.7658.0748.2350.9744.0545.28
Upgrade
Cash & Cash Equivalents
81.4549.7753.5162.460.7658.0748.2350.9744.0545.28
Upgrade
Cash Growth
63.66%-6.99%-14.24%2.69%4.63%20.42%-5.39%15.72%-2.73%38.93%
Upgrade
Receivables
47.2453.5738.5136.732.3429.1127.126.2523.2326.18
Upgrade
Inventory
67.8176.8461.2639.6241.9941.4945.0635.8235.534.84
Upgrade
Other Current Assets
14.112.638.96.053.965.26.416.389.977.79
Upgrade
Total Current Assets
210.6192.81162.19144.76139.05133.88126.79119.42112.75114.09
Upgrade
Property, Plant & Equipment
50.714937.4630.573030.5130.4527.4927.6126.09
Upgrade
Goodwill and Intangibles
190.43198.82197.38149.4877.7581.6391.8428.2831.0131.17
Upgrade
Other Long-Term Assets
11.369.18.230.674.583.762.958.095.575.4
Upgrade
Total Long-Term Assets
252.5256.92243.07180.72112.32115.9125.2463.8664.1862.66
Upgrade
Total Assets
463.1449.72405.26325.48251.38249.78252.03183.28176.93176.75
Upgrade
Accounts Payable
17.7611.711.977.246.267.727.636.654.975.59
Upgrade
Current Debt
2.52.632.3905.254.53.75000
Upgrade
Other Current Liabilities
37.732.8338.1713.6812.6610.6711.198.618.7714.03
Upgrade
Total Current Liabilities
57.9547.1652.5220.9124.1722.8922.5715.2513.7419.62
Upgrade
Long-Term Debt
33.7569.1184.0375.8244.9350.1554.61000
Upgrade
Other Long-Term Liabilities
3.345.1621.0837.776.867.168.382.162.172.09
Upgrade
Total Long-Term Liabilities
37.0974.26105.11113.651.7957.3162.992.162.172.09
Upgrade
Total Liabilities
95.04121.42157.63134.5175.9680.1985.5617.4115.921.7
Upgrade
Total Debt
36.2471.7486.4275.8250.1854.6558.36000
Upgrade
Debt Growth
-49.48%-16.99%13.97%51.10%-8.17%-6.36%----
Upgrade
Common Stock
155.41147.4140.2132.83129.19125.61122.36117.15111.85107.41
Upgrade
Retained Earnings
223.16180.7109.2963.1149.646.9249.6351.0548.8746.89
Upgrade
Comprehensive Income
-10.50.2-1.86-4.98-3.38-2.95-5.52-2.330.310.75
Upgrade
Shareholders' Equity
368.06328.3247.63190.97175.42169.59166.47165.87161.03155.05
Upgrade
Total Liabilities and Equity
463.1449.72405.26325.48251.38249.78252.03183.28176.93176.75
Upgrade
Net Cash / Debt
45.21-21.97-32.9-13.4310.583.43-10.1350.9744.0545.28
Upgrade
Net Cash / Debt Growth
----208.99%--15.72%-2.73%38.93%
Upgrade
Net Cash Per Share
1.02-0.50-0.76-0.310.250.08-0.241.211.051.08
Upgrade
Working Capital
152.65145.65109.67123.85114.88110.99104.22104.1799.0194.47
Upgrade
Book Value Per Share
8.457.595.784.494.144.023.963.983.883.76
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).